Characterisation of the second messenger pathway underlying neurite outgrowth stimulated by FGF.
Cerebellar neurons, cultured on monolayers of 3T3 fibroblasts or on a polylysine/laminin-coated substratum, responded to recombinant basic FGF by extending longer neurites. The response was biphasic reaching a maximum at 5 ng/ml FGF, but desensitising at 100-200 ng/ml FGF. The response to FGF could be inhibited by a tyrosine kinase inhibitor (the erbstatin analogue), by a diacylglycerol lipase inhibitor (RHC-80267) and by a combination of N- and L-type calcium channel antagonists or other agents that negate the effects of calcium influx into neurons. The response to FGF could be fully mimicked by arachidonic acid added directly to the cultures, or generated via activation of phospholipase A2 with melittin. The response to melittin, but not to FGF or arachidonic acid, was inhibited by 4-bromophenacyl bromide, a phospholipase A2 inhibitor. The response to arachidonic acid was also biphasic and high concentrations of this agent could cross-desensitise the FGF response and vice versa. The response to arachidonic acid could be fully inhibited by the agents that block or negate the effects of calcium influx into neurons, but was not inhibited by the tyrosine kinase or diacylglycerol lipase inhibitors. These data suggest that FGF stimulates neurite outgrowth by activating a cascade that involves activation of phospholipase C gamma to produce diacylglycerol, conversion of diacylglycerol to arachidonic acid by diacylglycerol lipase and the activation of voltage-gated calcium channels by arachidonic acid.
Williams
E J
EJ
Department of Experimental Pathology, UMDS, Guy's Hospital, London Bridge, London, UK.
Furness
J
J
Walsh
F S
FS
Doherty
P
P
D016475:3T3 Cells; D000818:Animals; D016718:Arachidonic Acid / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002478:Cells, Cultured; D002531:Cerebellum / Q000166:cytology; D003512:Cyclohexanones / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006873:Hydroquinones / Q000494:pharmacology; D008555:Melitten / Q000494:pharmacology; D051379:Mice; D016501:Neurites / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D009474:Neurons / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000494:pharmacology; D015290:Second Messenger Systems / Q000502:physiology*; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D002121:Calcium Channel Blockers; D003512:Cyclohexanones; D006873:Hydroquinones; D010566:Virulence Factors, Bordetella; D016222:Fibroblast Growth Factor 2; D008555:Melitten; D016718:Arachidonic Acid; C036535:1,6-bis(cyclohexyloximinocarbonyl)hexane; D011505:Protein-Tyrosine Kinases; D002118:Calcium; C048212:erbstatin